These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Epigenetics of Huntington's Disease. Bassi S; Tripathi T; Monziani A; Di Leva F; Biagioli M Adv Exp Med Biol; 2017; 978():277-299. PubMed ID: 28523552 [TBL] [Abstract][Full Text] [Related]
9. Neuroepigenetics of Aging and Age-Related Neurodegenerative Disorders. Lardenoije R; Pishva E; Lunnon K; van den Hove DL Prog Mol Biol Transl Sci; 2018; 158():49-82. PubMed ID: 30072060 [TBL] [Abstract][Full Text] [Related]
10. Epigenetic Modifications in Neurological Diseases: Natural Products as Epigenetic Modulators a Treatment Strategy. Gangisetty O; Murugan S Adv Neurobiol; 2016; 12():1-25. PubMed ID: 27651245 [TBL] [Abstract][Full Text] [Related]
11. Targeting epigenetics as a promising therapeutic strategy for treatment of neurodegenerative diseases. Zhang L; Liu Y; Lu Y; Wang G Biochem Pharmacol; 2022 Dec; 206():115295. PubMed ID: 36241096 [TBL] [Abstract][Full Text] [Related]
12. Epigenetic Basis of Lead-Induced Neurological Disorders. Wang T; Zhang J; Xu Y Int J Environ Res Public Health; 2020 Jul; 17(13):. PubMed ID: 32645824 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic modifications as novel therapeutic targets for Huntington's disease. Wang F; Fischhaber PL; Guo C; Tang TS Epigenomics; 2014 Jun; 6(3):287-97. PubMed ID: 25111483 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease? Harrison IF; Dexter DT Pharmacol Ther; 2013 Oct; 140(1):34-52. PubMed ID: 23711791 [TBL] [Abstract][Full Text] [Related]
15. Oxidative stress induces DNA demethylation and histone acetylation in SH-SY5Y cells: potential epigenetic mechanisms in gene transcription in Aβ production. Gu X; Sun J; Li S; Wu X; Li L Neurobiol Aging; 2013 Apr; 34(4):1069-79. PubMed ID: 23141413 [TBL] [Abstract][Full Text] [Related]
16. Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Urdinguio RG; Sanchez-Mut JV; Esteller M Lancet Neurol; 2009 Nov; 8(11):1056-72. PubMed ID: 19833297 [TBL] [Abstract][Full Text] [Related]
17. Epigenetic Changes and Its Intervention in Age-Related Neurodegenerative Diseases. Mohd Murshid N; Aminullah Lubis F; Makpol S Cell Mol Neurobiol; 2022 Apr; 42(3):577-595. PubMed ID: 33074454 [TBL] [Abstract][Full Text] [Related]
18. The roles of epigenetic modifications in neurodegenerative diseases. Qu W; Zhuang Y; Li X Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Oct; 50(5):642-650. PubMed ID: 34986527 [TBL] [Abstract][Full Text] [Related]
19. Epigenetic programming of neurodegenerative diseases by an adverse environment. Babenko O; Kovalchuk I; Metz GA Brain Res; 2012 Mar; 1444():96-111. PubMed ID: 22330722 [TBL] [Abstract][Full Text] [Related]
20. Epigenetic regulation of memory by acetylation and methylation of chromatin: implications in neurological disorders, aging, and addiction. Sen N Neuromolecular Med; 2015 Jun; 17(2):97-110. PubMed ID: 24777294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]